Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Journal of Primary Health Care Journal of Primary Health Care Society
Journal of The Royal New Zealand College of General Practitioners
RESEARCH ARTICLE (Open Access)

Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practice

Tess Brian 1 , Michael B. Jameson 2 3
+ Author Affiliations
- Author Affiliations

1 Department of Plastic and Reconstructive Surgery, Waikato Hospital, Hamilton, New Zealand

2 Oncology Department, Waikato Hospital, Hamilton, New Zealand

3 Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand

Correspondence to: Tess Brian, Department of Plastic and Reconstructive Surgery, Waikato Hospital, Selwyn Street and Pembroke Street, Hamilton 3204, New Zealand. Email: tessbrian0@gmail.com

Journal of Primary Health Care 10(3) 210-214 https://doi.org/10.1071/HC17055
Published: 4 October 2018

Journal Compilation © Royal New Zealand College of General Practitioners 2018.
This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Abstract

INTRODUCTION: New Zealand guidelines for cutaneous melanoma management recommend excision biopsy specimens of suspected lesions have a 2 mm horizontal margin, and a deep margin into upper subcutis.

AIM: To assess guideline compliance of suspicious lesion biopsies taken in the community and in a hospital.

METHODS: Patients admitted to Waikato Hospital, Hamilton, for diagnostic or treatment melanoma surgery during the year ending February 2016 were retrospectively identified, and their demographic and biopsy characteristics examined.

RESULTS: In total, 140 patients had excision biopsies: 61.4% were performed outside the hospital. Biopsy data were available for 126 specimens. Mean horizontal margin was greater (P = 0.001) in hospital biopsies (4.8 mm, standard deviation (s.d.) 3.7 mm) than biopsies performed elsewhere (2.8 mm; s.d. 1.8 mm). Horizontal margins >2.0 mm occurred in 70.6% of specimens; 21.6% of ≤2.0 mm specimens had a tumour-positive margin. Subsequent wide local excision identified residual melanoma in 9.6% of specimens, which was not associated (P = 0.3) with primary horizontal margin ≤2.0 mm. Mean deep margin of hospital biopsies (6.5 mm; s.d. 2.7 mm) was greater (P < 0.001) than in other biopsies (4.1 mm; s.d. 2.7 mm). Horizontal margin >2.0 mm specimens had greater (P < 0.001) mean deep margin (5.9 mm; s.d. 2.7 mm) than specimens with horizontal margin ≤2.0 mm (mean deep margin 3.3 mm; s.d. 2.7 mm). Deep margin ≤2.0 mm (19.0%) was independently associated with the facility where biopsy was performed (P = 0.001) and horizontal margin (P < 0.001).

DISCUSSION: The New Zealand biopsy deep margin recommendation does not lend itself to meaningful audit. Compliance with the horizontal margin recommendation was low, but of uncertain clinical significance.

KEYWORDS: audit, clinical; biopsy, skin; guideline adherence; melanoma, cutaneous malignant; New Zealand


References

[1]  New Zealand Ministry of Health. Cancer: New registrations and deaths 2013. Wellington: New Zealand Ministry of Health; 2016.

[2]  Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Wellington: The Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group; 2008.

[3]  National Melanoma Tumour Standards Working Group. Standards of Service Provision for Melanoma Patients in New Zealand - Provisional. Wellington: New Zealand Ministry of Health; 2013.

[4]  Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer (AJCC), Cancer Staging Manual. 7th edn. New York: Springer; 2010.

[5]  Roberts DL, Anstey AV, Barlow RJ, et al. UK guidelines for the management of cutaneous melanoma. Br J Dermatol. 2002; 146 7–17.
UK guidelines for the management of cutaneous melanoma.Crossref | GoogleScholarGoogle Scholar |

[6]  Coit DG, Thompson JA, Andtbacka R, et al. National Comprehensive Cancer Network (NCCN), Clinical Practice Guidelines in Oncology. Melanoma (Version 4.2014). Fort Washington: National Comprehensive Cancer Network; 2014.